The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience

• Main Authors: Mikhail M. Kostik (Author), Rinat K. Raupov (Author), Evgeny N. Suspitsin (Author), Eugenia A. Isupova (Author), Ekaterina V. Gaidar (Author), Tatyana V. Gabrusskaya (Author), Maria A. Kaneva (Author), Ludmila S. Snegireva (Author), Tatyana S. Likhacheva (Author), Rimma S. Miulkidzhan (Author), Artem V. Kosmin (Author), Anastasia V. Tumakova (Author), Vera V. Masalova (Author), Margarita F. Dubko (Author), Olga V. Kalashnikova (Author), Ivona Aksentijevich (Author), Vyacheslav G. Chasnyk (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

JAK-inhibitors are small molecules blocking the JAK-STAT pathway that have proven effective in the treatment of different immune-mediated diseases in adults and juvenile idiopathic arthritis (JIA).Aim of StudyTo evaluate the safety and efficacy of tofacitinib in children with different rheumatic dis...